Understanding how Sox9 helps liver bile duct development and healing

Establishing Sox9 as a regulator of intrahepatic bile duct development and regeneration

NIH-funded research Emory University · NIH-10848457

This study is looking at how a protein called Sox9 helps liver cells grow and heal bile ducts, which could lead to new treatments for liver diseases that don't have many options right now.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionEmory University NIH-funded
Lab location1 site (Atlanta, United States)
Project IDNIH-10848457 on NIH RePORTER

What this research studies

This research investigates the role of the Sox9 protein in the development and regeneration of bile ducts in the liver. By studying how Sox9 influences the behavior of liver cells, particularly during injury and disease, the research aims to uncover new insights into liver repair mechanisms. The approach includes using mouse models to observe the effects of Sox9 deficiency on bile duct formation and regeneration. This work could lead to the development of innovative therapies for liver diseases that currently have limited treatment options.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with liver diseases, particularly those related to bile duct dysfunction, such as Alagille Syndrome.

Not a fit: Patients with liver conditions unrelated to bile duct development or regeneration may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for liver diseases, improving healing and regeneration of bile ducts.

How similar studies have performed: Previous research has shown that understanding the role of specific proteins like Sox9 can lead to significant advancements in regenerative medicine, indicating potential success for this approach.

Where this research is happening

Atlanta, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alagille SyndromeAlagille-Watson Syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.